Harriet having it all
From Boston to Moscow and across the U.S., Harriet Latham Robinson SM ’61, PhD ’65 has balanced an exciting career at the forefront of molecular biology with family, friends, and adventure.
From Boston to Moscow and across the U.S., Harriet Latham Robinson SM ’61, PhD ’65 has balanced an exciting career at the forefront of molecular biology with family, friends, and adventure.
MIT researchers have designed an ultrasound system that creates a real-time 3D representation of the object being imaged.
Using a catheter coated with carbon nanotubes, researchers can detect biomarkers produced by cancer cells in the bladder.
Computational neuroscientist Sven Dorkenwald and cell biologist Whitney Henry, along with two MIT alumni, are recognized for their exceptional early-career research contributions.
Researchers can now use custom-built microscopy and nanotechnology to tag and follow the activity of individual proteins in real-time.
The MIT Marble Center for Cancer Nanomedicine looks back at 10 years of turning big ideas about nanotechnology into transformative advances for cancer patients.
Using immune-remodeling mRNA molecules, researchers generated T cells that can slow tumor growth and, in some cases, eradicate tumors.
A new study suggests that the chemical NDMA is much more likely to cause cancerous mutations after exposure early in life.
Long thought to be mainly a structural support, the cell membrane also influences how cells respond to signals and may contribute to the growth of cancer cells.
A backup survival pathway can help tumor cells resist certain lung cancer and other drugs. Combining therapies may offer a solution.
As an aspiring physician-scientist and editor-in-chief of The Tech, MIT senior Alex Tang has found inspiration in the lives of patients and others in his community.
Assistant Professor Matthew Jones is working to decode molecular processes on the genetic, epigenetic, and microenvironment levels to anticipate how and when tumors evolve to resist treatment.
Assistant Professor Alison Ringel will investigate the intersection of immunology and aging biology, aiming to define mechanisms that underlie aging-related decline, thanks to a grant from the foundation.
The new system could be used at home or in doctors’ offices to scan people who are at high risk for breast cancer.
Researchers uncover a hidden mechanism that allows cancer to develop aggressive mutations.